TrialBMC pulmonary medicine2011

Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results.

Miron A Bogdan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.